Purple Biotech (PPBT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.14, -7.32% vs the prior close of $1.23.
- Volume 20.47K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PPBT slides 7.3% to $1.14, a 52-week low, 4 down days in a row. Closed at $1.14, -7.32% vs the prior close of $1.23. Day range $1.13–$1.29, opened at $1.28.
PPBT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PPBT slides 7.3% to $1.14, a 52-week low, 4 down days in a row
- Closed at $1.14, -7.32% vs the prior close of $1.23. Day range $1.13–$1.29, opened at $1.28.
- Volume was 20.47K shares, 0.0x its 50-day average of 1.63M — lighter than usual.
- Price is -26.7% vs its 50-day average ($1.56) and -65.5% vs its 200-day average ($3.31).
- 52-week range $1.13–$14.10; today's close sits at 0% of that range, 91.9% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 — PPBT ends flat (+0.0%) to $1.23, 3 down days in a row
- Closed at $1.23, +0.00% vs the prior close of $1.23. Day range $1.19–$1.35, opened at $1.19.
- Volume was 40.50K shares, 0.0x its 50-day average of 1.63M — lighter than usual.
- Price is -21.2% vs its 50-day average ($1.56) and -63.1% vs its 200-day average ($3.33).
- 52-week range $1.16–$14.10; today's close sits at 1% of that range, 91.3% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — PPBT slides 9.6% to $1.23, a 52-week low
- Closed at $1.23, -9.56% vs the prior close of $1.36. Day range $1.23–$1.39, opened at $1.33.
- Volume was 52.90K shares, 0.0x its 50-day average of 1.62M — lighter than usual.
- Price is -21.5% vs its 50-day average ($1.57) and -63.4% vs its 200-day average ($3.36).
- 52-week range $1.16–$14.10; today's close sits at 1% of that range, 91.3% below the 52-week high.
Oct 13, 2026 — PPBT dips 1.4% to $1.36
- Closed at $1.36, -1.45% vs the prior close of $1.38. Day range $1.30–$1.40, opened at $1.37.
- Volume was 14.90K shares, 0.0x its 50-day average of 1.63M — lighter than usual.
- Price is -13.4% vs its 50-day average ($1.57) and -59.9% vs its 200-day average ($3.39).
- 52-week range $1.16–$14.10; today's close sits at 2% of that range, 90.4% below the 52-week high.
Oct 12, 2026 — PPBT jumps 3.8% to $1.38
- Closed at $1.38, +3.76% vs the prior close of $1.33. Day range $1.28–$1.39, opened at $1.33.
- Volume was 23.00K shares, 0.0x its 50-day average of 1.63M — lighter than usual.
- Price is -12.3% vs its 50-day average ($1.57) and -59.6% vs its 200-day average ($3.42).
- 52-week range $1.16–$14.10; today's close sits at 2% of that range, 90.2% below the 52-week high.
Oct 9, 2026 — PPBT slides 7.6% to $1.33, a 1-month low, 4 down days in a row
- Closed at $1.33, -7.64% vs the prior close of $1.44. Day range $1.33–$1.44, opened at $1.42.
- Volume was 26.80K shares, 0.0x its 50-day average of 1.63M — lighter than usual.
- Price is -15.5% vs its 50-day average ($1.57) and -61.4% vs its 200-day average ($3.45).
- 52-week range $1.16–$14.10; today's close sits at 1% of that range, 90.6% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — PPBT dips 1.4% to $1.44, 3 down days in a row
- Closed at $1.44, -1.37% vs the prior close of $1.46. Day range $1.41–$1.44, opened at $1.43.
- Volume was 9.60K shares, 0.0x its 50-day average of 1.63M — lighter than usual.
- Price is -8.6% vs its 50-day average ($1.57) and -58.6% vs its 200-day average ($3.48).
- 52-week range $1.16–$14.10; today's close sits at 2% of that range, 89.8% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — PPBT dips 0.7% to $1.46
- Closed at $1.46, -0.68% vs the prior close of $1.47. Day range $1.40–$1.48, opened at $1.44.
- Volume was 14.00K shares, 0.0x its 50-day average of 1.63M — lighter than usual.
- Price is -7.2% vs its 50-day average ($1.57) and -58.3% vs its 200-day average ($3.50).
- 52-week range $1.16–$14.10; today's close sits at 2% of that range, 89.6% below the 52-week high.
Oct 6, 2026 — PPBT slides 5.8% to $1.47
- Closed at $1.47, -5.77% vs the prior close of $1.56. Day range $1.45–$1.54, opened at $1.51.
- Volume was 9.40K shares, 0.0x its 50-day average of 1.63M — lighter than usual.
- Price is -6.5% vs its 50-day average ($1.57) and -58.4% vs its 200-day average ($3.53).
- 52-week range $1.16–$14.10; today's close sits at 2% of that range, 89.6% below the 52-week high.
Oct 5, 2026 — PPBT jumps 3.3% to $1.56
- Closed at $1.56, +3.31% vs the prior close of $1.51. Day range $1.41–$1.56, opened at $1.50.
- Volume was 33.70K shares, 0.0x its 50-day average of 1.63M — lighter than usual.
- Price is -0.7% vs its 50-day average ($1.57) and -56.2% vs its 200-day average ($3.56).
- 52-week range $1.16–$14.10; today's close sits at 3% of that range, 88.9% below the 52-week high.
- SEC filings that day: 6-K.
Oct 2, 2026 — PPBT dips 0.7% to $1.51, 3 down days in a row
- Closed at $1.51, -0.66% vs the prior close of $1.52. Day range $1.42–$1.52, opened at $1.42.
- Volume was 23.20K shares, 0.0x its 50-day average of 1.63M — lighter than usual.
- Price is -3.7% vs its 50-day average ($1.57) and -58.0% vs its 200-day average ($3.59).
- 52-week range $1.16–$14.10; today's close sits at 3% of that range, 89.3% below the 52-week high.
- That makes 3 straight losses.
PPBT latest news & SEC filings
Every SEC filing by or about PPBT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 9, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 2, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 7, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 29, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 23, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade PPBT
- How much it moves: over the last 20 sessions the average daily move was 2.59% (largest 9.6%).
- Liquidity: about 26.18K shares (≈$29.84K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.14 vs a range of $1.13–$14.10 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Mar 2, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 5, 2026; 6-K Sep 9, 2026; 6-K Sep 2, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
PPBT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.28 | 1.29 | 1.13 | 1.14 | 20.47K |
| Oct 15, 2026 | 1.19 | 1.35 | 1.19 | 1.23 | 40.50K |
| Oct 14, 2026 | 1.33 | 1.39 | 1.23 | 1.23 | 52.90K |
| Oct 13, 2026 | 1.37 | 1.40 | 1.30 | 1.36 | 14.90K |
| Oct 12, 2026 | 1.33 | 1.39 | 1.28 | 1.38 | 23.00K |
| Oct 9, 2026 | 1.42 | 1.44 | 1.33 | 1.33 | 26.80K |
| Oct 8, 2026 | 1.43 | 1.44 | 1.41 | 1.44 | 9.60K |
| Oct 7, 2026 | 1.44 | 1.48 | 1.40 | 1.46 | 14.00K |
| Oct 6, 2026 | 1.51 | 1.54 | 1.45 | 1.47 | 9.40K |
| Oct 5, 2026 | 1.50 | 1.56 | 1.41 | 1.56 | 33.70K |
| Oct 2, 2026 | 1.42 | 1.52 | 1.42 | 1.51 | 23.20K |
| Oct 1, 2026 | 1.49 | 1.53 | 1.40 | 1.52 | 12.30K |
| Sep 30, 2026 | 1.50 | 1.60 | 1.46 | 1.52 | 21.10K |
| Sep 29, 2026 | 1.47 | 1.53 | 1.44 | 1.52 | 29.40K |
| Sep 28, 2026 | 1.48 | 1.51 | 1.43 | 1.49 | 13.00K |
| Sep 25, 2026 | 1.48 | 1.54 | 1.40 | 1.51 | 25.90K |
| Sep 24, 2026 | 1.48 | 1.53 | 1.45 | 1.48 | 22.30K |
| Sep 23, 2026 | 1.45 | 1.55 | 1.43 | 1.49 | 47.00K |
| Sep 22, 2026 | 1.43 | 1.51 | 1.35 | 1.46 | 43.70K |
| Sep 21, 2026 | 1.42 | 1.54 | 1.40 | 1.43 | 40.40K |
About Purple Biotech
Purple Biotech (PPBT) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in REHOVOT, Israel. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 1614744.
PPBT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ido Agmon | Director | Apr 6, 2026 |
| Robert E. Gagnon | Director | Mar 18, 2026 |
| Simcha Rock | Director | Apr 17, 2026 |
| Suzana Zilberberg | Director | Apr 7, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Gil Efron | Chief Executive Officer | Mar 31, 2026 |
| Shai S Lankry | Chief Financial Officer | Mar 30, 2026 |
| Michael Schickler | Head of Clinical & Reg Affairs | Mar 30, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
PPBT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
PPBT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PPBT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.